Assessing Localized Tissue Response

Irritation Testing evaluates the potential of a medical device (or its extractables) to cause a localized inflammatory response when in contact with biological tissues such as skin or mucous membranes. Unlike sensitization, irritation is a non-immunological reaction that typically occurs shortly after a single or brief exposure.
 

1. Key Objectives

• Local Tolerance Assessment: To determine if chemical substances leaching from the device cause adverse effects like redness, swelling, or discomfort.

• Safety Verification: To ensure the device is biocompatible with the specific tissue it is intended to contact (e.g., skin, ocular, or mucosal surfaces).
   

2. Common Test Methods

The choice of test depends on the device's intended clinical use:

• Skin Irritation Test: Traditionally performed using rabbit models to observe reactions on intact skin.

• Mucosal Irritation Test: Essential for devices contacting the oral cavity, vagina, or eyes, where tissues are more permeable and sensitive.

• In Vitro Skin Irritation (ISO 10993-23): Modern regulatory trends favor the use of Reconstructed Human Epidermis (RhE) models to replace animal testing whenever possible.
   

3. Scoring and Interpretation: Primary Irritation Index (PII)

The severity of Erythema (redness) and Edema (swelling) is recorded at specific time intervals. These scores are used to calculate the Primary Irritation Index (PII), which categorizes the device's irritation potential from "Negligible" to "Severe."



Click to Pay